Using Botox to Reduce Pain in Children Undergoing Limb Lengthening Surgery
Author Information
Author(s): Hamdy Reggie C, Montpetit Kathleen, Ruck-Gibis Joanne, Thorstad Kelly, Raney Ellen, Aiona Michael, Platt Robert, Finley Allen, Mackenzie William, McCarthy James, Narayanan Unni
Primary Institution: Shriners Hospital for Children
Hypothesis
Can Botulinum Toxin A (BTX-A) alleviate post-operative pain and improve functional outcomes in children undergoing distraction osteogenesis?
Conclusion
The study aims to determine if BTX-A can effectively reduce pain and improve quality of life for children undergoing limb lengthening procedures.
Supporting Evidence
- BTX-A has been used worldwide with no major side effects reported.
- This is the first study using BTX-A in the context of limb lengthening.
- Previous studies suggest BTX-A can provide analgesic effects.
- Children treated with BTX-A had reduced need for narcotic analgesics in related studies.
Takeaway
This study is looking at whether giving kids Botox during surgery can help them feel less pain and recover better after their leg lengthening operations.
Methodology
A multi-center, randomized, double-blinded, placebo-controlled trial involving children aged 5-21 years undergoing limb lengthening or deformity correction.
Potential Biases
Potential bias in participant selection and reporting of outcomes due to the nature of the study design.
Limitations
The study may not account for all potential confounding variables and the long-term effects of BTX-A are not fully understood.
Participant Demographics
Children aged 5-21 years requiring limb lengthening or deformity correction.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website